Wednesday, January 27, 2021

China’s CoronaVac vaccine shows just 50% efficacy in Brazil

As wealthy countries snap up vaccines developed in the West, others are pinning their hopes on cheaper Chinese vaccines.

Other News

South Korean giant announces first overseas plant in Malaysia in another major pandemic-season investment

The Sabah plant will cater to the increasing global demand for copper foil which is crucial for electric vehicle batteries.

Gantung Parlimen, Anwar cabar PM di mahkamah

Anwar, selaku pemohon memfailkan permohonan itu di Mahkamah Tinggi Kuala Lumpur semalam menerusi Tetuan Karpal Singh & Co.

Pemimpin kanan DAP selar Noor Hisham

Ketua pengarah kesihatan itu didakwa menunjukkan kelemahannya dalam perang melawan Covid-19.

DAP leader hits out at Noor Hisham over ‘personal preferences’, ‘blind spots’

Liew Chin Tong criticises the DG for cautioning against the use of rapid test kits, adding that the government has 'practically abandoned' contact tracing as well.

Pasangan ‘PJJ’ boleh rentas negeri mulai esok, kata menteri

Kerajaan bersetuju memberi kelonggaran itu tetapi pasangan terbabit perlu mendapat kebenaran polis terlebih dahulu.

Results of a Brazilian trial show that the Covid-19 vaccine developed by China’s Sinovac Biotech is just 50.4% effective.

This means that it barely meets the threshold for regulatory approval and is well below the initially reported efficacy rate, according to several media reports.

Brazil, with just over eight million infections and more than 200,000 deaths, is the first country to complete a late-stage trial of the vaccine CoronaVac.

The state-run Butantan Institute in Sao Paulo has been criticised for a lack of transparency in making public its trial data. It reportedly delayed the release of trial results three times, blaming a confidentially clause in its contract with China.

The institute, which is the largest vaccine producer in Latin America and one of the largest in the world, announced last week that CoronaVac was 78% effective, but then on Tuesday said that the overall efficacy rate had fallen to 50.4%, reported the Wall Street Journal

In comparison, Covid vaccines from Pfizer-BioNTech and Moderna were found to be about 95% effective in their late-stage trials.

Brazil and other developing nations have pinned their hopes on Chinese vaccines as wealthier countries snap up vaccines developed in the West.

Sinovac’s vaccine is also cheaper and easier to transport because it can be stored in ordinary refrigerators unlike the vaccines from Pfizer-BioNTech and Moderna that must be kept at subfreezing temperatures.

Butantan has requested for CoronaVac to be authorized for emergency use in Brazil, reports Reuters.

The country’s health regulator Anvisa, which has stipulated a minimum 50% efficacy rate for vaccines to be approved, said it will meet on Sunday to decide.

As well as Brazil, other developing countries including Turkey and Indonesia are also conducting CoronaVac trials.

Indonesia on Monday approved the vaccine for emergency use, making it the first country outside China to do so after interim data from a late-stage trial showed that CoronaVac was 65.3% effective, reported Reuters.

Meanwhile, Turkish researchers said their interim analysis showed the vaccine to be 91.25% effective, Reuters reported last month.

Follow us on Telegram for the latest updates:

Subscribe to our newsletter

To be updated with all the latest news and analyses.

Related Articles

Death toll hits 700 as recoveries still outstrip new cases

3,585 new cases, 4,076 recoveries with 280 in ICU.

Indonesia passes one million Covid-19 cases

There are reports of patients being unable to access ICUs and isolation rooms due to high demand – a shortage underscored by an East Java city's move to outfit a train carriage to accommodate the sick.

Philippine president tells kids to stay home and watch TV

Philippine President Rodrigo Duterte has reimposed a ban on children aged 10 to 14 leaving home, a move which others say could hamper economic recovery.

Tiger euthanised in Covid-19 outbreak at Swedish zoo

Three gorillas at a California zoo are recovering from the virus in what experts believe is the first known case of transmission to primates.

Rich and poor vaccine divide worsening, warns WHO

WHO emergencies director says only one disease – smallpox – has ever been eradicated, so the availability of vaccines against Covid-19 does not mean the disease can be wiped off the face of the Earth.